-+ 0.00%
-+ 0.00%
-+ 0.00%

Helus Pharma Names Michael Halstead CEO

PUBT·11/16/2026 11:04:08
Helus Pharma Names Michael Halstead CEO
  • Helus Pharma appointed Michael Halstead as chief executive officer to lead late-stage development and commercialization.
  • Suresh Durgam joined the board. He previously served as executive vice president and chief medical officer of Intra-Cellular Therapies.
  • Board member Mark Lawson was appointed independent chair.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cybin Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611160600PRIMZONEFULLFEED9877720) on November 16, 2026, and is solely responsible for the information contained therein.